Logotipo do repositório
 

Publicação:
Impurities and Forced Degradation Studies: A Review

dc.contributor.authorKogawa, Ana C. [UNESP]
dc.contributor.authorSalgado, Herida R. N. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-11-26T15:29:22Z
dc.date.available2018-11-26T15:29:22Z
dc.date.issued2016-01-01
dc.description.abstractThe safety of pharmaceuticals is dependent not only on the intrinsic toxicological properties of the active ingredient, but also on the impurities and degradation products that it may contain. The presence of impurities in active ingredients can have a significant impact on the quality, safety and efficacy of pharmaceuticals. Efforts should be made to identify and characterize all unknown impurities in the drug, due to the increasing demand of regulatory agencies to manufacture high-purity drugs. The drug impurity profile is one of the most important issues in modern pharmaceutical analysis during the process of technology development for the production of high-purity substances. The degradation products may be provided through forced degradation studies, which enable development of indicators of stability methods with appropriate specificity and selectivity, purity verification chromatographic peak of active pharmaceutical ingredient in the product, provides information about possible degradation routes of a certain product, evaluation of the factors that may interfere in any way in the drug stability and critical analysis of the drug degradation profile.en
dc.description.affiliationUniv Estadual Paulista Julio de Mesquita Filho UN, Sch Pharmaceut Sci Araraquara, Dept Pharmaceut, Sao Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista Julio de Mesquita Filho UN, Sch Pharmaceut Sci Araraquara, Dept Pharmaceut, Sao Paulo, Brazil
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipPADC/FCF/UNESP (Araraquara, Brazil)
dc.description.sponsorshipU.S. Pharmacopeial Convention
dc.format.extent18-24
dc.identifierhttp://dx.doi.org/10.2174/1573412911666150519000155
dc.identifier.citationCurrent Pharmaceutical Analysis. Sharjah: Bentham Science Publ Ltd, v. 12, n. 1, p. 18-24, 2016.
dc.identifier.doi10.2174/1573412911666150519000155
dc.identifier.issn1573-4129
dc.identifier.urihttp://hdl.handle.net/11449/158830
dc.identifier.wosWOS:000374885500003
dc.language.isoeng
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCurrent Pharmaceutical Analysis
dc.relation.ispartofsjr0,224
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectDegradation products
dc.subjectdegradation profile
dc.subjectforced degradation
dc.subjectimpurities
dc.subjectquality
dc.subjectpharmaceuticals
dc.titleImpurities and Forced Degradation Studies: A Reviewen
dc.typeResenhapt
dcterms.rightsHolderBentham Science Publ Ltd
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos